Selskabets formål er kommercialisering af immunmonitorerings metoder
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 22.7 mio. | -11 mio. | 49.1 mio. | 16.1 mio. | 40 | |
CVR: 31348854
Previous names: ApS KBIL 17 NR. 2544, INITIO ApS
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Hans Christian Barré Pedersen joined the board
Jamil El-Ali joined the board
Helene Kähler Hjenner left the board
Companies in the same industry and area
CVR 30703464
CVR 32780571
CVR 39398486
CVR 46284771
CVR 41760834